Avisa Pharma Inc - Product Pipeline Analysis, 2017 Update

Summary

Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The companys product include avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic diseases; and avisar spec, a point-of-care instrument that is used for measuring exhaled carbondioxide. Its AV-U13 drug for inhalation and nebulizer are packaged in a disposable breath collection kit to test the presence of pathogens. Avisa Pharmas avisa breath test kit provides immediate information of the presence of certain urease pathogens in the lung. The companys products find clinical applications for pneumonia in the emergency department, ventilator associated pneumonia, chronic obstructive pulmonary disease exacerbations, and tuberculosis. It caters to hospitals, emergency departments, coronary care units, nursing units, urgent care centers and retail clinics. Avisa Pharma is headquartered in Santa Fe, New Mexico, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Avisa Pharma Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Avisa Pharma Inc Company Overview 4
Avisa Pharma Inc Company Snapshot 4
Avisa Pharma Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Avisa Pharma Inc Pipeline Analysis Overview 7
Avisa Pharma Inc - Key Facts 7
Avisa Pharma Inc - Major Products and Services 8
Avisa Pharma Inc Pipeline Products by Development Stage 9
Avisa Pharma Inc Pipeline Products Overview 11
Avisa BreathTest - Chronic Obstructive Pulmonary Disease 11
Avisa BreathTest - Chronic Obstructive Pulmonary Disease Product Overview 11
Avisa BreathTest - Cystic Fibrosis 12
Avisa BreathTest - Cystic Fibrosis Product Overview 12
Avisa BreathTest - Healthcare-Acquired Pneumonia 13
Avisa BreathTest - Healthcare-Acquired Pneumonia Product Overview 13
Avisa BreathTest - Tuberculosis 14
Avisa BreathTest - Tuberculosis Product Overview 14
Avisa BreathTest - Ventilator-Associated Pneumonia 15
Avisa BreathTest - Ventilator-Associated Pneumonia Product Overview 15
AVISAR SPEC 16
AVISAR SPEC Product Overview 16
Avisa Pharma Inc - Key Competitors 17
Avisa Pharma Inc - Key Employees 18
Avisa Pharma Inc - Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Avisa Pharma Inc, Recent Developments 20
Sep 21, 2016: Avisa Selected as a Best University Startup for its Novel BreathTest Point-of-Care Diagnostic for Respiratory Infections 20
Dec 18, 2015: Avisas Biomarker Breath Test Detects Tuberculosis in South Africa Pilot Study 20
Appendix 21
Methodology 21
About GlobalData 23
Contact Us 23
Disclaimer 24

List Of Tables


Avisa Pharma Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Avisa Pharma Inc Pipeline Products by Equipment Type 5
Avisa Pharma Inc Pipeline Products by Indication 6
Avisa Pharma Inc, Key Facts 7
Avisa Pharma Inc, Major Products and Services 8
Avisa Pharma Inc Number of Pipeline Products by Development Stage 9
Avisa Pharma Inc Pipeline Products Summary by Development Stage 10
Avisa BreathTest - Chronic Obstructive Pulmonary Disease - Product Status 11
Avisa BreathTest - Chronic Obstructive Pulmonary Disease - Product Description 11
Avisa BreathTest - Cystic Fibrosis - Product Status 12
Avisa BreathTest - Cystic Fibrosis - Product Description 12
Avisa BreathTest - Healthcare-Acquired Pneumonia - Product Status 13
Avisa BreathTest - Healthcare-Acquired Pneumonia - Product Description 13
Avisa BreathTest - Tuberculosis - Product Status 14
Avisa BreathTest - Tuberculosis - Product Description 14
Avisa BreathTest - Ventilator-Associated Pneumonia - Product Status 15
Avisa BreathTest - Ventilator-Associated Pneumonia - Product Description 15
AVISAR SPEC - Product Status 16
AVISAR SPEC - Product Description 16
Avisa Pharma Inc, Key Employees 18
Glossary 22

List Of Figures


Avisa Pharma Inc Pipeline Products by Equipment Type 5
Avisa Pharma Inc Pipeline Products by Development Stage 9

Avisa Pharma Inc - Product Pipeline Analysis, 2019 Update

Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company provides product such as avisa breath test

USD 750 View Report

Avisa Pharma Inc. - Medical Equipment - Deals and Alliances Profile

Avisa Pharma Inc. (Avisa Pharma) is a clinical stage company that develops technologies for early tuberculosis (TB) detection. The companys product include AVISAR system designed to detect respiratory bacterial infections

USD 250 View Report

Ocuphire Pharma Inc (OCUP) - Financial and Strategic SWOT Analysis Review

Ocuphire Pharma Inc (Ocuphire Pharma), formerly Rexahn Pharmaceuticals Inc, is an ophthalmic biopharmaceutical company that develops and commercializes medicines to treat eye disorders. It is investigating Nyxol, a preservative-free ophthalmic

USD 300 View Report

PDL BioPharma Inc - Strategic SWOT Analysis Review

PDL BioPharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available